Enveda Gains Backing from Sanofi to Advance AI-Driven Drug Discovery to Clinical Trials Bringing Total Series C Financing to $150M
February 26, 2025 09:00 AM Eastern Standard Time BOULDER, Colo.–(BUSINESS WIRE)–Enveda, a leading biotechnology company harnessing life’s chemistry to discover better medicines, today announced an investment from Sanofi, a leading healthcare company. This investment reaffirms the…